GraversenPAbildstromSZJespersenLet al.Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study. Eur J Prev Cardiol2016; 23: 1546–1556.
2.
PiepoliMFHoesAWAgewallSet al.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
3.
WangZHaoGZhangLet al.Central systolic blood pressure is associated with ethnicity and cardiovascular disease risk factors in Chinese middle-aged population. Eur J Prev Cardiol2016; 23: 228–236.
4.
LinhartCTivollierJMTaylorRet al.Changes in cardiovascular disease risk factors over 30 years in Polynesians in the French Pacific Territory of Wallis Island. Eur J Prev Cardiol2016; 23: 856–864.
5.
MontLPellicciaASharmaSet al.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol2017; 24: 41–69.
6.
SabbagASidiYKivitySet al.Obesity and exercise induced ectopic ventricular arrhythmias in apparently healthy middle aged adults. Eur J Prev Cardiol2016; 23: 511–517.
7.
KotsevaKWoodDDe BacquerDet al.on behalf of the EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol2016; 23: 636–648.
8.
ZhaoMCooneyMTKlipstein-GrobuschKet al.Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries. Eur J Prev Cardiol2016; 23: 1202–1210.
9.
MunkhaugenJSverreEOtterstadJEet al.Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients. Eur J Prev Cardiol2017; 24: 981–989.
10.
Muller-WielandDAssmannGCarmenaRet al.Treat to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk. Eur J Prev Cardiol2016; 23: 275–281.
11.
SoranHAdamSDurringtonPN. Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat. Eur J Prev Cardiol2017; 24: 76–83.
12.
Fernandes-SilvaMMGuimaraesGVRigaudVOet al.Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial. Eur J Prev Cardiol2017; 24: 808–817.
13.
KraalJJvan den Alkker-Van MarleMEAbu-HannaAet al.Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre based cardiac rehabilitation: Results of the FIT@Home study. Eur J Prev Cardiol2017; 24: 1260–1273.
14.
FrederixISolmiFPiepoliMFet al.Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits. Eur J Prev Cardiol2017; 24: 1708–1717.
